PATENT CLAIM ANALYSIS

Application Number: 16151113
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-03
Patent Classification: ["514", "738000"]

Abstract:
The present invention provides compositions and methods of their use in treating muscular dystrophy and other disorders.

Claim (Index 5):
The method of  claim 2 , wherein the disorder associated with a mutation or loss of function in the FKRP gene is selected from the group consisting of limb-girdle muscular dystrophy (LGMD2I), Walker-Warburg syndrome (WWS), muscle-eye-brain disease (MEB), congenital muscular dystrophy type (MDC1C), and any combination thereof.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 97.0
- Lexical Diversity: 1.05882
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16151126', '15842580', '16112447', '16151137', '15880283']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.87834504703321
- 35 USC 102 Novelty (BERT): 0.6069284806859021
- Combined Prediction Score: 0.8512033903984793
- Mean Citation Score: 586.107384
- Max Citation Score: 641.59375
- Similarity Product: 466.4711989406496

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test